Grid ViewAny timeRelevance

Search results for ' W MARKET CENTER DR'.

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

Rediff.com11 Jun 2024

The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. According to the latest data from US-based Centers for Medicare and Medicaid Services (CMMS), price erosion in calendar year 2024 (CY24) on a year-to-date (YTD) basis stood at a high of 15 per cent in the oral solid dosage (OSD) segment compared to a low of 1 per cent in CY23. This erosion, according to a report by Antique Stock Broking, was the highest in the last three years.

NASA will soon train Indian astronauts for joint ISS mission: Garcetti

NASA will soon train Indian astronauts for joint ISS mission: Garcetti

Rediff.com25 May 2024

National Aeronautics and Space Administration will soon provide advanced training to Indian astronauts, with the goal of mounting a joint effort to the International Space Station, a top American diplomat said Friday.

'We were listed in the global top 10 start-ups in sustainability'

'We were listed in the global top 10 start-ups in sustainability'

Rediff.com8 Feb 2024

'We want to make sustainability affordable.' 'We tell everyone, don't just recycle, Craste it!'

Infosys partners with Microsoft to accelerate adoption of GenAI

Infosys partners with Microsoft to accelerate adoption of GenAI

Rediff.com27 Sep 2023

Infosys said on Tuesday it is collaborating with Microsoft to jointly develop industry solutions that leverage Infosys Topaz, Azure OpenAI Service and Azure Cognitive Services. Both organisations are bringing together their respective artificial intelligence (AI) capabilities to enhance enterprise functions with AI-enabled solutions across multiple industries. The integrated solutions are aimed at accelerating the rapid democratisation of data and intelligence that will help businesses increase productivity and drive new revenue growth.

The A-W Of Desi Guests At the White House Dinner

The A-W Of Desi Guests At the White House Dinner

Rediff.com24 Jun 2023

The dinner Jill Biden and her husband US President Joe Biden hosted for Indian prime minister Narendra Modi, June 22, at the White House brought together, Indians and Americans from so many firmaments.

'A lot has been done between India and the US in the last two years than it was done before'

'A lot has been done between India and the US in the last two years than it was done before'

Rediff.com23 Jun 2023

'With Trump, the relationship was very transactional, whereas with President Biden it is very structured.'

WHO criticises China for withholding Covid origin data

WHO criticises China for withholding Covid origin data

Rediff.com18 Mar 2023

"We continue to call on China to be transparent in sharing data and to conduct the necessary investigations and share the results. Understanding how the pandemic began remains both a moral and scientific imperative," Ghebreyesus said.

Full text: President Murmu's address to Parliament's Budget Session

Full text: President Murmu's address to Parliament's Budget Session

Rediff.com31 Jan 2023

'Wherever in the world there is political instability, those countries are beset with severe crises today. But India is in a much better position than the rest of the world due to the decisions taken by my government in the national interest,' President Droupadi Murmu said in her address to both Houses of Parliament.

'Xi will wait for the Modi government to make the reconciliation moves'

'Xi will wait for the Modi government to make the reconciliation moves'

Rediff.com20 Oct 2022

'Which will not happen.' 'Foreign Minister S Jaishankar has expressly refuted Beijing's statement that normalcy was returning to Sino-Indian relations.'

Can Religious Rows Hurt DMK In 2024?

Can Religious Rows Hurt DMK In 2024?

Rediff.com21 Sep 2022

Party insiders concede statements of the Raja kind have the potential to hurt the DMK's electoral chances in closely-fought seats in 2024, observes N Sathiya Moorthy.

'If Putin succeeds, Russia will be an unquestioned great power'

'If Putin succeeds, Russia will be an unquestioned great power'

Rediff.com25 Feb 2022

'The aim of Russian policy is to reform European security, stop NATO expansion and in a more general sense -- set up the new rules of relations between the great powers.' 'From this perspective. the invasion of Ukraine is quite pointless.'

'Everybody's going to get infected'

'Everybody's going to get infected'

Rediff.com27 Dec 2021

'In the likelihood that Omicron is circulating, you have a much greater chance of getting infected now, than you did during the Age of Delta.'

Russia's Sputnik Light vaccine gets phase 3 SEC trial nod

Russia's Sputnik Light vaccine gets phase 3 SEC trial nod

Rediff.com15 Sep 2021

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation has recommended the conduct of Phase III clinical trials of Russia's single dose COVID-19 vaccine Sputnik Light.

India Sitting on COVID Time Bomb

India Sitting on COVID Time Bomb

Rediff.com12 Aug 2021

Whether the third wave will ravage us depends on the pace of vaccinations, careful and calibrated opening up of establishments, and a strategy to contain the spread in specific states or pockets.

Govt expects speedy launch of single-dose Sputnik Light vaccine

Govt expects speedy launch of single-dose Sputnik Light vaccine

Rediff.com27 May 2021

The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application and regulatory approval procedures for the jab to boost the country's vaccination drive, sources said.

Report indicates Wuhan scientists got sick with Covid before outbreak

Report indicates Wuhan scientists got sick with Covid before outbreak

Rediff.com24 May 2021

Three researchers from the Wuhan Institute of Virology sought hospital care in November 2019, weeks before Beijing disclosed the COVID-19 pandemic, a United States media report said, citing a previously undisclosed American intelligence document that could add weight to growing calls for a full scale probe of whether the coronavirus may have escaped from China's top bio lab.

Sputnik V production begins in India; 100mn jabs to be manufactured per year

Sputnik V production begins in India; 100mn jabs to be manufactured per year

Rediff.com24 May 2021

Domestic pharma major Panacea Biotec in collaboration with Russian sovereign wealth fund Russian Direct Investment Fund (RDIF) has begun the production of 'Sputnik V' COVID-19 vaccine in India, according to a joint statement issued.

COVID-19: Take the first available vaccine to you

COVID-19: Take the first available vaccine to you

Rediff.com21 Apr 2021

'All the vaccines that are available in most countries, right now, are all highly effective and safe.'

North India could see 100,000 cases per state per day

North India could see 100,000 cases per state per day

Rediff.com19 Apr 2021

'The trajectory of the disease will keep increasing because of the population density being very high.'

Will the farmers get justice?

Will the farmers get justice?

Rediff.com19 Dec 2020

The government has the upper hand in the ongoing negotiations, and it is unclear if a real debate will happen, observes Tulika Narayan.

India biggest buyer of Covid vaccine with 1.6 bn doses

India biggest buyer of Covid vaccine with 1.6 bn doses

Rediff.com4 Dec 2020

India has purchased 500 million doses of the Oxford University-AstraZeneca vaccine candidate, one billion from the United States company Novavax and 100 million doses of the Sputnik V candidate from Russia's Gamaleya Research Institute, according to the US-based Duke University Global Health Innovation Center.

RDIF, Hetero to produce over 100 mn doses of Russian vaccine in India

RDIF, Hetero to produce over 100 mn doses of Russian vaccine in India

Rediff.com27 Nov 2020

The parties intend to start the production of Sputnik V in the beginning of 2021, it added. Currently, Phase III clinical trials are approved and are ongoing in Belarus, the United Arab Emirates, Venezuela and other countries, as well as Phase II-III in India, RDIF said.

Russian vaccine has efficacy of over 95%: RFID CEO

Russian vaccine has efficacy of over 95%: RFID CEO

Rediff.com24 Nov 2020

In a virtual conference from Moscow, Dmitriev said Sputnik V is not only 'one of the most effective' but also among the 'affordable' vaccines in the world.

'Attempt to change status quo at LAC is unacceptable'

'Attempt to change status quo at LAC is unacceptable'

Rediff.com4 Nov 2020

As the pandemic unfolded, the India-China relationship has come under severe stress. To restore normalcy, agreements between the two countries must be respected scrupulously in their entirety. Where the Line of Actual Control is concerned, any attempt to unilaterally change the status quo is unacceptable, declares External Affairs Minister Dr Subrahmanyam Jaishankar.

Coronavirus made in Wuhan lab, claims Chinese virologist

Coronavirus made in Wuhan lab, claims Chinese virologist

Rediff.com14 Sep 2020

The expose, which was in Chinese, said that the Chinese Communist Party was covering up the COVID-19 crisis and there was a human-to-human transmission of the virus.

COVID-19: 'Good behaviour will reduce deaths'

COVID-19: 'Good behaviour will reduce deaths'

Rediff.com27 Aug 2020

'We cannot be naughty and expect the government to do good!' 'We have to behave ourselves and then we can expect the government to support us.' 'If we are able to protect ourselves well, then we should not be having deaths.' 'Unfortunately, people have gotten into this super scary event participation (mode) -- birthday parties, large gatherings.' 'Among the people who have attended those, 80 to 90 per cent of them have come down with COVID-19.'

'If everyone wore a face mask, this thing will be gone tomorrow!'

'If everyone wore a face mask, this thing will be gone tomorrow!'

Rediff.com22 Jul 2020

'The majority of the spread is by people coughing, or sneezing or talking loudly, in a very short distance, two metres from one another, and a mask will prevent that sort of transmission.'

'Talent is everywhere and relevant to a nation's success'

'Talent is everywhere and relevant to a nation's success'

Rediff.com9 Jul 2020

'Everybody says 5G and communication is important.' 'Everybody says automation, robotics, human computing interfaces -- people and machines working together -- is the future.' 'Everybody agrees that cybersecurity is something that is here to stay.' 'Everybody agrees that synthetic biology is important.' 'Instead of outlining thinking about industries for tomorrow and the future, let the evolutionary pathway be built in a way that it promotes robust, creative, thinking.'

'Coronavirus is airborne': Over 200 scientists write to WHO

'Coronavirus is airborne': Over 200 scientists write to WHO

Rediff.com6 Jul 2020

The WHOS has long held that the coronavirus is spread primarily by large respiratory droplets when an infected person coughs or sneezes.

India's COVID-19 Crisis May Get Worse

India's COVID-19 Crisis May Get Worse

Rediff.com15 Jun 2020

'As people have moved from cities to small towns and villages, they have carried the infection into new territories.' 'Poor healthcare infrastructure in these places should be a big worry in the days to come.'

'Emergence of another coronavirus is inevitable'

'Emergence of another coronavirus is inevitable'

Rediff.com13 May 2020

'The worst case scenario is a rebound of the virus.' 'Life is not going to be what it was.' 'Life as we know it has changed forever.' 'The new normal therefore is test, trace and treat.'

Exploring a cheap sanitiser to fight coronavirus

Exploring a cheap sanitiser to fight coronavirus

Rediff.com10 Apr 2020

'If it works, something good can come out of this tragedy for the common public good,' say Dr Prasad Gadgil and Dr Kunal Basu.

Why didn't China warn the world in December?

Why didn't China warn the world in December?

Rediff.com27 Mar 2020

The reality is, the worldwide toll could have been checked within time if China had been more transparent and had warned countries regarding the new strain of Severe Acute Respiratory Syndrome (SARS)-like infection, which originated at a 'wet market' in its province of Hubei late last year.

'Modi is a master of this kind of political theatre'

'Modi is a master of this kind of political theatre'

Rediff.com27 Sep 2019

'I give Modi full credit, for brilliantly using his personal diplomacy, his personal stature, to accomplish his goals...'

'700 children in India die of diarrhoea or pneumonia every day'

'700 children in India die of diarrhoea or pneumonia every day'

Rediff.com14 Jun 2019

'This is a tragedy that must be stopped.'

Sports Shorts: 'Neeraj recovering without complications'

Sports Shorts: 'Neeraj recovering without complications'

Rediff.com16 May 2019

Summary of sports events and persons who made news on Thursday

Trump fear forces old enemies to thaw ties

Trump fear forces old enemies to thaw ties

Rediff.com30 Oct 2018

'Both Japan and China face a common challenge: How to deal with Trump.' 'The trade war with the US seems to have facilitated/hastened Abe's China visit, the first by a Japanese prime minister since 2011,' points out Dr Rajaram Panda.

RBI rate hike a 'win-win' situation for markets, banks, says SBI report

RBI rate hike a 'win-win' situation for markets, banks, says SBI report

Rediff.com3 Aug 2018

The SBI report ruled out a October rate hike

Men, this could be the reason for erectile dysfunction

Men, this could be the reason for erectile dysfunction

Rediff.com15 Feb 2018

These could be the reasons for erectile dysfunction.

6 million reasons why you should know this cancer scientist

6 million reasons why you should know this cancer scientist

Rediff.com27 Sep 2017

Dr Manjiri Bakre's OncoStem is revolutionising breast cancer treatment. And has raised $6 million to do more!

Next